Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             33 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit Bostner, Josefine
2012
137 2 p. 397-406
artikel
2 Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer Hayashi, Naoki
2012
137 2 p. 523-531
artikel
3 Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients Eggemann, Holm
2012
137 2 p. 465-470
artikel
4 Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage Conroy, Susan K.
2012
137 2 p. 493-502
artikel
5 A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer Ma, Cynthia X.
2012
137 2 p. 483-492
artikel
6 A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer Cristofanilli, Massimo
2012
137 2 p. 471-482
artikel
7 Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk Wang, Hong
2012
137 2 p. 511-522
artikel
8 Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis Pabalan, Noel
2012
137 2 p. 553-558
artikel
9 Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case–control study Bilinski, K.
2012
137 2 p. 599-607
artikel
10 Comments on the use of a single or multiple probe-set approach for microarray-based analyses of routine molecular markers in breast cancer Coradini, Danila
2012
137 2 p. 647-651
artikel
11 Differential expression of immune-related markers in breast cancer by molecular phenotypes Choi, Junjeong
2012
137 2 p. 417-429
artikel
12 Effect of HER2 status on distant recurrence in early stage breast cancer Hess, Kenneth R.
2012
137 2 p. 449-455
artikel
13 Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer Dean-Colomb, Windy
2012
137 2 p. 631-636
artikel
14 Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features Jambal, Purevsuren
2012
137 2 p. 431-448
artikel
15 Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population Jara, Lilian
2012
137 2 p. 559-569
artikel
16 Impact of breast cancer on anti-mullerian hormone levels in young women Su, H. I.
2012
137 2 p. 571-577
artikel
17 Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis Antoni, Sebastien
2012
137 2 p. 337-347
artikel
18 MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Bockhorn, Jessica
2012
137 2 p. 373-382
artikel
19 Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program Cunningham, Joan E.
2012
137 2 p. 589-598
artikel
20 Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations Prokofyeva, Darya
2012
137 2 p. 533-539
artikel
21 One-day core needle biopsy in a breast clinic: 4 years experience Bulte, Joris P.
2012
137 2 p. 609-616
artikel
22 Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior Forsythe, Laura P.
2012
137 2 p. 617-630
artikel
23 Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen Yardley, Denise A.
2012
137 2 p. 457-464
artikel
24 Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes Hanker, Lars C.
2012
137 2 p. 407-416
artikel
25 PTP1B expression is an independent positive prognostic factor in human breast cancer Soysal, S.
2012
137 2 p. 637-644
artikel
26 Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age Li, Christopher I.
2012
137 2 p. 579-587
artikel
27 Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism Allensworth, Jennifer L.
2012
137 2 p. 359-371
artikel
28 The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer Wallwiener, Markus
2012
137 2 p. 503-510
artikel
29 Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry Zhang, Fang Fang
2012
137 2 p. 541-551
artikel
30 Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype Brown, Kevin D.
2012
137 2 p. 329-336
artikel
31 Trastuzumab administration during pregnancy: a systematic review and meta-analysis Zagouri, Flora
2012
137 2 p. 349-357
artikel
32 Unincluded subjects need to be included for concerning the real association between TNFa−308 G/A polymorphism and cancer susceptibility Zhang, Guoqiang
2012
137 2 p. 645-646
artikel
33 Vimentin DNA methylation predicts survival in breast cancer Ulirsch, Jacob
2012
137 2 p. 383-396
artikel
                             33 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring